Starting treatment: latest news

Starting treatment resources

Starting treatment features

Starting treatment in your own words

Starting treatment news from aidsmap

More news

Starting treatment news selected from other sources

  • Immediate HIV Treatment Has Little Impact on Risk of Future Drug Resistance

    Starting antiretroviral therapy (ART) immediately rather waiting until a person's CD4 count falls below 500 cells/µL has almost no impact on the person's risk of developing antiretroviral resistance over the next seven years, according to a study published online in the journal AIDS. In this 51,000-person analysis, the impact of immediate ART on acquired drug resistance disappeared almost completely among people starting treatment in 2005 or later.

    07 January 2018 | The Body Pro
  • NHS England have announced funding for immediate antiretroviral treatment for HIV patients

    NHS England has announced that it has agreed that HIV antiretroviral medication will be provided to patients immediately once someone is diagnosed.

    19 December 2017 | Gay Times
  • Who Resists Starting ART Therapy for HIV?

    The study found that the demographic characteristics of patients who failed to initiate ART within 2 years of entering care were not as important as clinical factors. Higher CD4 count, lower viral load, and a prevalent AIDS diagnosis were clinical characteristics associated with delayed ART initiation.

    07 September 2017 | MD Mag
  • Globally, People With HIV Are Starting Treatment Earlier

    But the median CD4 count at treatment start is below 350, which means work is needed to catch up to World Health Organization guidelines.

    21 August 2017 | Poz
  • Lesotho HIV sites see ART start-up increases around 80%

    A universal treatment program has increased by 79% the average monthly number of people initiating HIV therapy at a group of relief sites in Lesotho, according to a CDC epidemiologist.

    21 August 2017 | Healio
  • Terrence Higgins Trust and BHIVA advise on the use of generic HIV antiretroviral therapy

    We believe that people living with HIV should be at the heart of decisions made about their care. Therefore decisions around switching to generic HIV medication should be based on a full discussion between a person living with HIV and their HIV clinician.

    16 August 2017 | Terrence Higgins Trust
  • Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

    The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.

    23 July 2017 | World Health Organization
  • Study: 1 in 3 Patients Starts HIV Treatment Late in 10 Countries

    A large team of international researchers has found 30 percent of HIV positive individuals in nearly a dozen countries delay starting life-saving drugs. A study spearheaded by the U.S. Centers for Disease Control and Prevention looked at the prevalence of HIV in Haiti, Vietnam, Nigeria, Namibia, Swaziland, Zimbabwe, Mozambique, Tanzania, Uganda and Zambia.

    09 June 2017 | Voice of America
  • Gay New Zealand welcomes removal of HIV meds restriction

    The decision of New Zealand's drug regulator Pharmac to remove a restriction on when people newly-diagnosed with HIV can be put on medications will "significantly benefit people newly diagnosed with HIV and those living with HIV as well as efforts to prevent HIV transmission” according to the NZ AIDS Foundation. “New Zealand is one of few countries in the developed world to still have a restriction on treatment access,” the NZAF's Executive Director Jason Myers says. “Early treatment is a fundamental pillar of NZAFs Ending HIV programme."

    08 May 2017 | Gay New Zealand
  • Should Antiretroviral Therapy be Offered the Same Day as Diagnosis?

    Andy Seale summarizes a discussion that took place on ITPC’s listserv about when to initiate antiretroviral therapy. The discussion included consideration of WHO’s recommendation for Same Day Start.

    23 March 2017 | ITPC
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.